A novel class of small molecule inhibitors of HDAC6

ACS Chemical Biology

Volumn 7, Issue 2, 2012, Pages 331-339

  Inks, Elizabeth S ^a   Josey, Benjamin J ^a   Jesinkey, Sean R ^a   Chou, C James ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANTILEUKEMIC AGENT; BENZAMIDE DERIVATIVE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; FLT3 LIGAND; HEAT SHOCK PROTEIN 90; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 11; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 6 INHIBITOR; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; HYDROXAMIC ACID DERIVATIVE; METAL; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NAPHTHOQUINONE; NSC 95397; STAT5 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CHELATION; CONTROLLED STUDY; CYTOSKELETON; DEACETYLATION; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SELECTIVITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN FAMILY; RNA SPLICING; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; LEUKEMIA, MYELOID, ACUTE; SMALL MOLECULE LIBRARIES;

EID: 84857509386     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200134p     Document Type: Article

References (43)

1. Minucci, S. and Pelicci, P. G. (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 6, 38-51 (Pubitemid 43054973)
2. Kouzarides, T. (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179 (Pubitemid 30151013)
3. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325, 834-840
4. Jenuwein, T. and Allis, C. D. (2001) Translating the histone code Science 293, 1074-1080 (Pubitemid 32758077)
5. Lee, K. K. and Workman, J. L. (2007) Histone acetyltransferase complexes: one size doesn't fit all Nat. Rev. Mol. Cell Biol. 8, 284-295 (Pubitemid 46474661)
6. Gregoretti, I. V., Lee, Y. M., and Goodson, H. V. (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 338, 17-31 (Pubitemid 38429783)
7. Smith, B. C., Hallows, W. C., and Denu, J. M. (2008) Mechanisms and molecular probes of sirtuins Chem. Biol. 15, 1002-1013
8. Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 272, 408-411 (Pubitemid 26138177)
9. Sternson, S. M., Wong, J. C., Grozinger, C. M., and Schreiber, S. L. (2001) Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin Org. Lett. 3, 4239-4242 (Pubitemid 33627255)
10. Bolden, J. E., Peart, M. J., and Johnstone, R. W. (2006) Anticancer activities of histone deacetylase inhibitors Nat. Rev. Drug Discovery 5, 769-784 (Pubitemid 44348499)
11. Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., and Marks, P. A. (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases Proc. Natl. Acad. Sci. U.S.A. 95, 3003-3007 (Pubitemid 28135844)
12. Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A., Steffan, J. S., Marsh, J. L., Thompson, L. M., Lewis, C. M., Marks, P. A., and Bates, G. P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. U.S.A. 100, 2041-2046 (Pubitemid 36254570)
13. Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., and Gottesfeld, J. M. (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia Nat. Chem. Biol. 2, 551-558 (Pubitemid 44413238)
14. Wang, L., de Zoeten, E. F., Greene, M. I., and Hancock, W. W. (2009) Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells Nat. Rev. Drug Discovery 8, 969-981
15. Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfi, A., Koch, U., De Francesco, R., Steinkuhler, C., and Gallinari, P. (2007) Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases Proc. Natl. Acad. Sci. U.S.A. 104, 17335-17340 (Pubitemid 350219843)
16. Schuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., McLean, T. H., Bochkarev, A., Plotnikov, A. N., Vedadi, M., and Arrowsmith, C. H. (2008) Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity J. Biol. Chem. 283, 11355-11363
17. Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., and Mazitschek, R. (2010) Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 6, 238-243
18. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A. M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., Boesche, M., Delling, M., Dumpelfeld, B., Eberhard, D., Huthmacher, C., Mathieson, T., Poeckel, D., Reader, V., Strunk, K., Sweetman, G., Kruse, U., Neubauer, G., Ramsden, N. G., and Drewes, G. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes Nat. Biotechnol. 29, 255-265
19. Miller, T. A., Witter, D. J., and Belvedere, S. (2003) Histone deacetylase inhibitors J. Med. Chem. 46, 5097-5116 (Pubitemid 37414179)
20. Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X. F., and Yao, T. P. (2002) HDAC6 is a microtubule- associated deacetylase Nature 417, 455-458 (Pubitemid 34563539)
21. Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., and Matthias, P. (2003) HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo EMBO J. 22, 1168-1179 (Pubitemid 36313600)
22. Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., Seto, E., and Bhalla, K. (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors J. Biol. Chem. 280, 26729-26734 (Pubitemid 41040705)
23. Kekatpure, V. D., Dannenberg, A. J., and Subbaramaiah, K. (2009) HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling J. Biol. Chem. 284, 7436-7445
24. Tessier, P., Smil, D. V., Wahhab, A., Leit, S., Rahil, J., Li, Z., Deziel, R., and Besterman, J. M. (2009) Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors Bioorg. Med. Chem. Lett. 19, 5684-5688
25. Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., and Shoichet, B. K. (2005) High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 1, 146-148
26. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108
27. Yang, X. J. and Seto, E. (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men Nat. Rev. Mol. Cell Biol. 9, 206-218 (Pubitemid 351301825)
28. Chou, C. J., Herman, D., and Gottesfeld, J. M. (2008) Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases J. Biol. Chem. 283, 35402-35409
29. Brandl, A., Heinzel, T., and Kramer, O. H. (2009) Histone deacetylases: salesmen and customers in the post-translational modification market Biol. Cell 101, 193-205
30. Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., and Anderson, K. C. (2005) Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma Proc. Natl. Acad. Sci. U.S.A. 102, 8567-8572 (Pubitemid 40862776)
31. Rao, R., Fiskus, W., Yang, Y., Lee, P., Joshi, R., Fernandez, P., Mandawat, A., Atadja, P., Bradner, J. E., and Bhalla, K. (2008) HDAC6 inhibition enhances 17-AAG - mediated abrogation of hsp90 chaperone function in human leukemia cells Blood 112, 1886-1893
32. Lin, T. Y., Fenger, J., Murahari, S., Bear, M. D., Kulp, S. K., Wang, D., Chen, C. S., Kisseberth, W. C., and London, C. A. (2010) AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit Blood 115, 4217-4225
33. Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., and Kozikowski, A. P. (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A J. Am. Chem. Soc. 132, 10842-10846
34. Quentmeier, H., Reinhardt, J., Zaborski, M., and Drexler, H. G. (2003) FLT3 mutations in acute myeloid leukemia cell lines Leukemia 17, 120-124 (Pubitemid 36175896)
35. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J. F., Capiod, J. C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. (1996) STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients Blood 87, 1692-1697 (Pubitemid 26068885)
36. Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., and Schreiber, S. L. (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation Proc. Natl. Acad. Sci. U.S.A. 100, 4389-4394 (Pubitemid 36457739)
37. Dokmanovic, M., Perez, G., Xu, W., Ngo, L., Clarke, C., Parmigiani, R. B., and Marks, P. A. (2007) Histone deacetylase inhibitors selectively suppress expression of HDAC7 Mol. Cancer Ther. 6, 2525-2534 (Pubitemid 47480418)
38. Zimmermann, S., Kiefer, F., Prudenziati, M., Spiller, C., Hansen, J., Floss, T., Wurst, W., Minucci, S., and Gottlicher, M. (2007) Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice Cancer Res. 67, 9047-9054 (Pubitemid 47535889)
39. McQuown, S. C., Barrett, R. M., Matheos, D. P., Post, R. J., Rogge, G. A., Alenghat, T., Mullican, S. E., Jones, S., Rusche, J. R., Lazar, M. A., and Wood, M. A. (2011) HDAC3 is a critical negative regulator of long-term memory formation J. Neurosci. 31, 764-774
40. Suzuki, T., Kouketsu, A., Itoh, Y., Hisakawa, S., Maeda, S., Yoshida, M., Nakagawa, H., and Miyata, N. (2006) Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate J. Med. Chem. 49, 4809-4812 (Pubitemid 44201038)
41. Itoh, Y., Suzuki, T., Kouketsu, A., Suzuki, N., Maeda, S., Yoshida, M., Nakagawa, H., and Miyata, N. (2007) Design, synthesis, structure-selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors J. Med. Chem. 50, 5425-5438 (Pubitemid 350057852)
42. Aldana-Masangkay, G. I., Rodriguez-Gonzalez, A., Lin, T., Ikeda, A. K., Hsieh, Y. T., Kim, Y. M., Lomenick, B., Okemoto, K., Landaw, E. M., Wang, D., Mazitschek, R., Bradner, J. E., and Sakamoto, K. M. (2011) Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells Leuk. Lymphoma 52, 1544-1555
43. Namdar, M., Perez, G., Ngo, L., and Marks, P. A. (2010) Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents Proc. Natl. Acad. Sci. U.S.A. 107, 20003-20008